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Francisella tularensis (Ft) is a highly infectious bacterium that causes tularemia, which 
manifests in multiple presentations such as ulceroglandular, pneumonic, or typhoidal forms. 
Pneumonic tularemia, a more severe manifestation, can result from inhalation of as few as 10 
colony forming units of Ft. The low infectious dose, its potential for aerosolization, and severity 
of disease has resulted in Ft classification as a Select Agent by the CDC for bioweapon potential. 
The severe clinical and financial burden a bioweapon attack utilizing Ft would impose on the 
U.S. makes development of therapeutics and vaccines an important contribution to protecting 
public health. Determination of vaccine targets requires knowledge of the early pathogenesis of 
Ft in the lungs. Ft infects a wide variety of cells, including lung macrophages and lung epithelial 
cells, likely involved in initial infection from aerosol; few have compared the permissivity of 
infection between these cell types to infection by Ft. We utilized an in vitro infection assay with 
murine macrophages (J774) and human alveolar epithelial cells (A549), and developed an ex 
vivo infection assay for 3D-cultured human primary bronchial epithelium (HBE), intended to 
mimic lung architecture. Early cellular events within SCHU S4 infected rabbit tissue, a model 
which exhibits clinical disease similar to humans, was assessed for cellular infiltration, changes 
in lung architecture, and apoptosis. I found that different strains of Ft (SCHU S4, LVS, and 
U112), grow at similar rates in A549 as J774 after initial infection. Moreover, I have 
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demonstrated that Ft can infect HBE in the 3D culture system. These data suggest that it takes Ft 
longer to infect the HBE cells than the A549 or J774 cells. This is the first infection assay 
performed within a 3D HBE culture, to our knowledge. Over the course of the first five days 
post-exposure there is an increasing amount of inflammation, hemorrhaging and apoptosis in 
rabbit lung. When taken altogether, these data suggest lung epithelial cells have an 
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1.0  INTRODUCTION 
1.1 TULAREMIA 
Tularemia is the disease caused by Francisella tularensis. Humans can be infected by 
multiple routes including a bite by an arthropod vector, contact with an infected animal or 
carcass, ingestion of contaminated water or food and inhalation of the organism. It is not 
transmitted from human -to -human. Francisella is endemic in several areas of the world. The 
outbreaks of tularemia do not seem to follow any specific pattern from year-to-year. It is 
typically a seasonal disease. The incidence is highest from late spring to early fall [1]. There was 
an outbreak in the Rostov-on-Don region of the Soviet Union during 1941-42, in which 67,000 
cases were reported. The United States has had several outbreaks; however, only 14,000 cases 
were reported from 1920 to 1945. The number of reported cases worldwide has decreased since 
the 1950s. Between 1990 and 2000, the United States only had 1,400 reported cases [1].  
1.2 HUMAN INFECTION 
As mentioned previously, humans can be infected by Francisella tularensis through 
multiple routes. Each route shows different clinical presentation. The disease course is similar to 
other infectious diseases, which can make diagnosis difficult. The incubation period can range 
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from 1-21 days; however, the typical incubation period is 3-5 days. The disease onset is very 
rapid. It includes fever, chills, fatigue, body aches and headache. The bacteria replicate rapidly at 
the beginning of infection. The immunologic response is very important in controlling the 
disease. Cell-mediated responses are more important than antibody-mediated responses because 
the antibodies do not play an important role in preventing the disease or lessening severity. 
However, antibodies can be good for diagnosis [1].  
The strains from the subspecies tularensis (Type A) can cause significant mortality if left 
untreated. There are occasional cases of rhabdomyolosis and septic shock associated with disease 
caused by the subspecies tularensis. With the advent of effective antibiotics, the mortality rate is 
less than two percent. However, when the disease is untreated, the mortality rate can be as high 
as thirty to sixty percent. The symptoms of disease caused by this subspecies include: high fever, 
progressive weakness, malaise, anorexia, weight loss, dry cough, sore throat, substernal pain and 
occasionally gastrointestinal symptoms [1].  
The subspecies holarctica (Type B) is typically transmitted via infected water, it can also 
be transmitted the same ways as Type A strains. The predominant symptom associated with 
Type B infection is fever. There have been more cases of tularemia caused by Type B strains 
than Type A strains worldwide. Type B strains are not as virulent as Type A strains, but can 
cause substantial morbidity and mortality. The disease caused by the subspecies mediasiatica is 
similar to that caused by the subspecies holarctica and is rarely reported in humans [1].  
The subspecies novicida is avirulent in humans. Occasionally, it will cause disease in 
immunocompromised individuals. It has been reported in four individuals in the United States. 
Three of the four cases were in immunocompromised individuals. It has caused disease in 
several individuals in Canada, Australia and Spain too [1].  
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Respiratory illness is caused by inhalation of aerosolized F. tularensis. The respiratory 
illness may present initially as pneumonia. The respiratory disease varies greatly between Type 
A and Type B strains. The symptoms associated with Type A caused disease are chills, high 
fever, dyspnea, dry or productive cough, pharyngitis, chest pain, headache, profuse sweating, 
drowsiness and weakness. The symptoms can be severe and resemble typhoid fever. The disease 
caused by Type B strains varies. Some outbreaks have a small percentage of cases with 
pneumonia like symptoms. Other outbreaks have a high percentage of pulmonary changes [1]. 
1.3 ANIMAL MODELS 
Francisella infects a wide range of mammals. Hares, prairie dogs, voles, squirrels, 
beavers, mice and many others can all be infected with Francisella. The spread of Francisella in 
the Soviet Union was thought to have been caused by voles and mice. Also, several people have 
become infected after running a rabbit or rabbit den over with the lawn mower. Therefore, there 
is a broad range of animal models available. However, tularemia in many animal species has not 
been characterized [1]; therefore, it is difficult to find an appropriate animal model [2]. Several 
animals used in tularemia research are guinea-pigs, rabbits, rats, mice and monkeys. 
1.3.1 Rabbits 
The clinical presentation of Francisella infection in rabbits is like humans. The rabbits 
can develop a fever, lose weight, experience lethargy, decreased appetite and occasional 
diarrhea. Francisella can infect many organs in a rabbit’s body. For example, lung, spleen, liver, 
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kidney, intestine, and lymph node involvement has been found during Francisella infection. 
These organs have been involved in the human infection as well [2].  
1.3.2 Mice 
Mice have been used extensively in tularemia research. Mice vary from humans in 
susceptibility to different strains of Francisella. They are susceptible to both tularensis and 
holarctica subspecies of Francisella. There is initially a reduced inflammatory response to 
infection with either strain [1]. Mice infected with SCHU S4 experience ruffled fur, lethargy, 
anorexia and hunching with infected via aerosol and intranasally. Like humans, mice can have 
lung, spleen and liver involvement [2].  
1.4  FRANCISELLA TULARENSIS 
Francisella tularensis is a gram-negative facultative intracellular bacterium that causes 
tularemia. Francisella is in a group of bacteria with Listeria, Legionella and Rickettsia [1]. F. 
tularensis can infect a broad range of hosts, including humans. The disease varies based on route 
of infection and bacterial subtype [3].  
The intracellular life cycle for Francisella tularensis has been studied in murine 
macrophages. First, F. tularensis is phagocytosed and remains in the Francisella-containing 
phagosome. F. tularensis is released into the macrophage cytosol after the phagosome membrane 
is disrupted. There is extensive replication in the cytosol. Eventually the bacteria are released 
when the cells undergo cell death. The cycle then repeats itself [4].  
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1.4.1 U112 
There are two avirulent subspecies of F. tularensis as well: mediasiatica and novicida 
[5]. Infection with F. tularensis subsp. novicida is extremely rare in humans. Strain U112, which 
is used in this study, is in the subspecies novicida. F. novicida can be transmitted through 
ingestion of infected water. Unlike F. tularensis there are no known animal or arthropod hosts 
for F. novicida [6], but U112 is able to enter and replicate within amoebas [7]. 
1.4.2 Live Vaccine Strain 
An attenuated strain of F. tularensis holarctica, the Live Vaccine Strain (LVS), is used in 
this study. The LVS strain is originally derived from a strain used as a vaccine in the Soviet 
Union. During World War II, there was an outbreak of tularemia among the Soviet soldiers [8]. 
There were 67,000 cases of tularemia reported in 1941-42 in the Soviet Union [1]. LVS was 
developed to help reduce the number of tularemia cases among the soldiers. There was a 
reduction of tularemia cases; however, sanitation improvements could also explain the reduction. 
In 1956, the Soviet Union gave the strain to investigators at Fort Detrick. The investigators 
further attenuated the pathogen to give to at-risk personnel. The reasons for LVS attenuation 
remain unknown because the parent strain is unknown. Therefore, the LVS strain cannot be used 
as a vaccine because of the potential to revert [8]. LVS is the most commonly studied strain of F. 
tularensis because it mimics many of the features of virulent F. tularensis in culture but can be 
safely work with at BSL-2. 
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1.4.3 SCHU S4 
The virulent strain of F. tularensis subsp. tularensis used in this study is SCHU S4. 
SCHU S4 was originally isolated from a patient in Ohio in 1941 [2]. SCHU S4 is the prototype 
strain of virulent F. tularensis that is studied in laboratories.  
1.5 CELL TYPES   
It is widely believed that the major targets of F. tularensis are macrophages and dendritic 
cells [3]. However, F. tularensis can infect a wide variety of eukaryotic cell types including 
hepatocytes, osteoblasts, epithelial cells, erythrocytes, and even fresh water amoeba [2, 5, 9, 10]. 
Considering that the respiratory infectious dose is 15 CFU in humans, the bacterium’s initial 
interactions in the respiratory tract are likely to be with epithelial cells. Therefore, it seems 
reasonable that F. tularensis infection of lung epithelial cells in early pathogenesis of this 
pathogen in order to develop a vaccine to prevent infections.  
1.5.1 Murine Macrophages 
The J774 cell line was derived from a BALB/cN female mouse with reticulum cell 
sarcoma [11]. This cell line is a macrophage-like cell line [12]. J774 cells have been used to 
determine the best lysing solution when working with Francisella [13]¸ the cytokine and 
chemokine patterns during Francisella infection [14], and the factors involved in the Francisella 
Type IV section system [15]. 
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1.5.2 Human Alveolar Epithelium 
The A549 cell line was derived from a 58-year-old male with carcinoma [16]. These cells 
are alveolar type II epithelial cells [12]. A549 cells have been used to study Francisella entry via 
micropinocytosis [17], immune suppression [17], differences in 2D and 3D cell culture responses 
to infection [18], ability of Francisella to infect human lung epithelium [12] and adherence to 
nonphagocytic cells [19]. 
1.5.3 Human Primary Lung Epithelium 
Most epithelial cell research in vitro is done with 2D monolayer cell cultures. However, 
these cell cultures are very different from the structure of the cells in the lungs. Cells cultured in 
a monolayer on hard plastic lose certain phenotypic characteristics. This results in changes in 
their function, biochemistry and morphology [18]. More recently 3D cell cultures have been used 
to more accurately model the lung epithelium. Cells in 3D cultures have cilia, apical-basal 
polarity, and produce mucus unlike 2D monolayers.  
For example, A549 cells grown in a flask do not display the same phenotypic 
characteristics as A549 cells grown using rotary wall vessel (RWV) bioreactors. The RWV 
bioreactor rotates the vessel horizontally. The cells are in a constant free-fall within the culture. 
This allows the cells to attach to one another creating a tissue-like phenotype. A549 cells grown 
in the RWV suspension culture have tight junctions and adherens junctions. A549 cells in 2D 
culture have type IV collagen localization in the nucleus, but 3D cultured have basolateral 
surface localization. There are also differences in the presence of laminin. Collagen and laminin 
are important in adhesion of the cells to the extracellular matrix. This suggests that there is 
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polarization of the A549 cells in RWV cultures. A549 monolayer cultures produce very low 
levels of respiratory mucins and the production of the mucins is intracellularly. The 3D cultures 
of A549 cells show higher levels of mucin production at the apical side of the culture, indicating 
proper mucin location for mucous production [20]. RWV cultured A549 cells seem to be more 
resistant to F. tularensis infection suggesting that 3D cultures better predict what was going on in 
vivo during infection.  
By using a 3D culture, the ability of F. tularensis to infect human primary epithelial cells 
can be evaluated. Therefore, the use of the 3D cultures may give us a better idea of what is going 
on in the lung epithelium during infection with F. tularensis.  
1.6 CELL DEATH 
1.6.1 Types of cell death 
There are three known types of cell death: necrosis, apoptosis and pyroptosis. For 
apoptosis, activated proteases and ATP is required. Cells undergoing apoptosis maintain cell 
membrane integrity until the late stages of the process. During necrosis, cell membrane damage 
occurs either directly or indirectly. Cells undergo energy depletion, swell and leak their 
cytoplasmic contents. Pyroptosis is a caspase-1 dependent form of necrosis. Apoptosis does not 
elicit a high inflammatory response; whereas, pyroptosis and necrosis do [21].   
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1.6.2 Apoptosis 
In apoptosis, cells maintain membrane integrity up until they are engulfed by the 
phagocytes. This type of cell death does not cause an immunologic response. Therefore, a 
pathogen could be causing cell death without triggering an inflammatory response. Although, the 
pathogen may activate the phagocytes that engulf the dead cells [22]. Apoptosis has initiator and 
effector caspases. The initiator caspases include caspase-2, 8, and 9. The effector caspases are 
caspase-3, 6, and 7. 
 There are two apoptosis pathways: extrinsic pathway and intrinsic pathway. The extrinsic 
pathway is activated by extracellular ligands and death receptors. This pathway uses caspases 3, 
6, 7, 8, and 10. During the intrinsic apoptosis signaling, cytochrome c is released from the 
mitochondria. It activates the formation of the apoptosome which recruits pro-caspase-9.  Pro-
caspase-9 gathers by the apoptosome, which activate it. The apoptosome cleaves pro-caspase-3 
into caspase 3. Caspase-3 cleaves ICAD into CAD, which ultimately cleave the DNA in the 
nucleus [23].  Cell shrinkage and blebbing are characteristics of cells undergoing apoptosis. 
1.6.3 Pyroptosis 
Two different types of programmed cell death have been well described, which include 
those that fall under the category of either apoptosis or pyroptosis. Pyroptosis is commonly 
caused by infections with pathogens. This type of cell death does have an inflammatory 
response. IL-1α, IL-1β, and IL-18 are commonly released causing the inflammatory response 
[22]. Pyroptosis is inflammasome-dependent. There are several caspases involved in this 
process: caspase-1 and mouse caspase-11.  
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Pyroptosis can be triggered by cell damage.  Bacterial toxins or activation of the P2X7 
receptor are two examples of cell damage known to activate pyroptosis. After activation, 
potassium is released from the cell. NLRP3 is activated when the chaperones dissociate due to 
efflux of potassium. Several NLRP3 domains interact with the adaptor protein ASC. The CARD 
domains of ASC aggregate causing the CARD domains of caspase-1 to aggregate. The caspase-1 
is then cleaved into its’ active form. The active caspase-1 then cleaves immature pro-
inflammatory cytokines including IL-18 and IL-1β. Alternatively, there is a caspase-1 
independent inflammasome pathway. Caspase-11 detects intracellular lipopolysaccharide [23]. In 
pyroptosis there is in influx of fluid, causing the cell to swell and ultimately lyse [22].  
 
1.7 PUBLIC HEALTH SIGNIFICANCE 
Francisella tularensis is an ideal biological warfare agent for many reasons. Its’ low 
infectious dose and aerosol delivery make it an ideal agent. SCHU S4 was weaponized in the 
past by the Soviet Union and the United States [8]. While tularemia is treatable, it is important to 
have a vaccine for it. Since there is not a vaccine, research on how the virulent strain infects 
versus the less virulent strains is very important. It could provide information on how to create a 
vaccine against the agent. Therefore, it would be easier to prevent natural outbreaks as well as to 
protect against its’ use in biological warfare.  
 
11 
2.0  SPECIFIC AIMS 
 Currently, the early pathogenesis of Francisella in lung epithelial cells is unknown. This 
project focuses on the ability of Francisella to infect and replicate within lung epithelial cells 
and cell death and inflammation in rabbit lung tissues. This will be accomplished by 
comparing results from in vitro work with transformed cell lines, human primary lung cells and 
tissue samples from infected rabbits.  
2.1 AIM 1: TO USE AN IN VITRO MODEL OF INFECTION WITH LVS AND SCHU 
S4 IN HUMAN ALVEOLAR EPITHELIUM AND HUMAN PRIMARY LUNG 
EPITHELIUM 
 The goal of this aim is to determine if Francisella tularensis can infect human 
alveolar epithelium (A549) and human primary lung epithelium (HBE) and establish 
infection assay protocols. This will be accomplished by: 
a. Performing infection assays to determine if F. tularensis can infect
human primary lung epithelium
b. Determining growth rates of F. tularensis in both A549 and
primary lung epithelium
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c. Establish an infection assay protocol for the human primary lung
epithelium
2.2 AIM 2: PATHOGENESIS OF SCHU S4 IN RABBIT LUNG TISSUE 
 The goal of this aim is to determine whether the animal model correlates with the in 
vitro and ex vivo models. This correlation will be assessed by: 
a. Determining the presence and concentration of F. tularensis in the
tissue samples
b. Determining whether cell death is occurring in the tissue samples
c. Determining if inflammation and hemorrhaging are increasing
each day post-exposure in the tissue samples
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3.0  MATERIALS AND METHODS 
3.1 BIOSAFETY 
All work with the SCHU S4 strain of Francisella was done in BSL-3+ laboratories. Work 
with this agent included wearing a disposable gown, rubber work boots, double gloves and a 
powered air purifying respirator (PAPR). All materials used during work with agent were 
disinfected with vesphene, double bagged and autoclaved. Work with U112 and LVS strains of 
bacteria was done in BSL3+ as well as BSL2 laboratories. The same procedures for BSL3+ as 
above were used. The BSL2 procedures include working in a Class II Biosafety cabinet, with 
gloves and splashguard gown. Bleach is used as a disinfectant in the BSL2 laboratories. 
3.2 RABBITS 
Female New Zealand White rabbits were housed in the BSL-3 laboratory. Temperature 
chips were implanted prior to exposure. The studies were approved by University of Pittsburgh’s 
IACUC. Animals were exposed via aerosol in the class-III biosafety cabinet. Plethysmography 
data was collected to determine dose. Aerosol was calculated by multiplying the all-glass 
impinger (AGI) (CFU/mL) by the AGI volume (10 mLs) by the aerosol time (1/10 min) by the 
AGI flow rate (1 min/6 L). The dose was calculated by multiplying the aerosol (CFU/L) by 
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minute volume (mL/min) by a conversion factor (1L/1000mL) by the duration of the aerosol (10 
min). The bronchoalveolar lavage was collected at time of necropsy by inserting 10 mL PBS into 
the lungs and removing the PBS from the lungs. Dilutions were made and plated on CHA plates.   
3.3 CELL CULTURE 
The A549 and J774 cell lines were originally obtained from the ATCC. The J774 cells 
were then cryopreserved in FBS containing 10% DMSO, and stored in a LN2 freezer. The A549 
cells were then cryopreserved in a base medium of DMEM-10 containing 10% DMSO, and 
stored in a LN2 freezer. The cells are thawed by diluting the vial contents with DMEM-10 media 
containing 1x penicillin and streptomycin, and 10% fetal bovine serum, and ultimately removing 
the cells from the DMSO containing freezing medium through a series of washes. The cells are 
centrifuged at 600xg for 5 minutes for each wash step. Then the cells are resuspended in 
DMEM-10 containing 1x penicillin and streptomycin, and 10% fetal bovine serum and put in a 
flask. Cells are split every few days when they reach confluency. J774 cells are removed from 
the flask using a cell scrapper. A549 cells are removed from the flask using 2 mL trypsin after 3 
washes with PBS.  
3.4 BACTERIA 
Three F. tularensis strains of varying virulence were used in this project. A F. tularensis 
subspecies novicida strain (U112), a F. tularensis subspecies holarctica strain (LVS), and a F. 
 15 
tularensis subspecies tularensis strain (SCHU S4) were used. These strains are the most 
commonly used in laboratories to look at intracellular infection by F. tularensis. The SCHU S4 
and LVS strains are grown for 48 hours before use. The U112 strain is grown for 24 hours before 
use because it grows at an accelerated rate on CHA compared to LVS and SCHU S4.  
3.5 INFECTION ASSAY 
Two days pre-infection, LVS and SCHU S4 is streaked onto a CHA plate. One-day pre-
infection cells are harvested and centrifuged for 5 minutes at 600xg in DMEM-10 with 
antibiotics. The cells are resuspended in 10-15 mLs of DMEM-10 without antibiotics. The cells 
are counted using a hemocytometer and concentration is adjusted to 300,000 cells/mL. One mL 
of cells is put into each well of a 12-well plate. The plates are placed in the incubator overnight 
at 37 °C and 5% CO2. U112 is streaked onto a CHA plate one day pre-infection as well. On the 
day of infection, a loop full of bacteria is mixed into PBS and read on the microplate reader or 
spectrophotometer. Once the OD is close to the desired OD (0.08 for the plate reader in the BLS-
2 lab and 0.1 for the spectrophotometer in the BSL-3 lab; wavelength: 600), the media is dumped 
out of the wells and 100 μL of the PBS solution is added to each well. The plates are incubated 
for 2 hours at 37°C with 5% CO2. At the end of the incubation period, the wells are washed 3 
times with PBS containing 50 μg/mL of gentamicin. Then 1 mL of media containing 50 μg/mL 
of gentamicin is added to each well. The plates incubated for 1 hour at 37°C and 5% CO2. At the 
end of the incubation period, the cells are washed with PBS without antibiotics. 0.02-1% SDS is 
added to the 0 hours post-infection (HPI) wells, while 2 ml of DMEM-10 containing 2 μg/mL of 
gentamicin is added to the remaining wells. After waiting 10 minutes for the SDS to lyse the 
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cells, the cell lysate is serially diluted to 10-5 and plated on CHA quad plates. The bacterial 
inoculum is serially diluted as well out to 10-8 and plated on CHA quad plates. The plates are 
placed in the incubator at 37°C and 5% CO2. At the 24, 48 and 72-hour time points the cells are 
lysed, serially diluted and plated the same way as above. The colonies are counted 48 hours after 
being plated for LVS and SCHU S4, while the U112 plates are counted 24 hours after being 
plated. The infection efficiency was calculated by taking the CFU at 0 HPI and dividing it by the 
inoculum. Doubling was calculated by subtracting the log of 0 HPI multiplied by 3.32 from the 
log of the other timepoints.  
3.6 HBE INFECTION ASSAY 
Two days prior to infection, LVS and/or SCHU S4 was streaked onto a CHA plate. The 
cells were obtained from Mike Myerburg’s lab (Division of Pulmonary, Allergy and Critical 
Care Medicine, University of Pittsburgh, Department of Medicine). The media was removed, 
wells washed with PBS and antibiotic free media was added. Cells were washed with DTT then 
PBS three times to remove extracellular debris and mucous. The bacterial inoculum was 
prepared by taking a sample of the bacteria off of the plates and mixing it into PBS. The 
inoculum was adjusted using OD. Once the desired OD was reached, 50 µl of the inoculum was 
added to the top of each well. The plates were incubated at 37°C for 2 hours. The inoculum was 
removed from the 0 HPI wells. The cells were incubated with 100 µl PBS with 50 µg/mL 
gentamicin for an hour. The cells were washed with PBS 3 times. The last wash volume was 
brought up to 1 mL. Dilutions were made and plated. The cells were then lysed with 0.02% SDS 
up to a total volume of 1 mL. A pipette tip was used to help lyse the cells. The tip was moved in 
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circles around the well inserts then in cross motions. Once the cells were lysed, dilutions were 
made and 50 µl were plated on CHA quad plates. The plates were incubated at 37°C for 48-72 
hours and the colonies were counted. The cells were lysed at 0 and 24 HPI. See results section 
for assay development.  
3.7 CASPASE-3 FLUORESCENT ASSAY IN CELL CULTURES 
This protocol is adopted from the Abcam Caspase 3 Assay Kit manual (ab39383). The 
infection assay will be performed as described above until the lysing step. The cells will be 
harvested by adding 100 µl trypsin to each well. After the cells detach from the plate, 900 µl of 
DMEM-10 without antibiotics is added. The cells are pelleted by centrifugation at 6000xg for 5 
minutes. The cells are washed with PBS, counted and 1-5 x 106 cells are pelleted by 
centrifugation. The pellet is resuspended in 50 μL of chilled Cell Lysis Buffer. The solution is 
incubated on ice for 10 minutes. The samples can be frozen at -80°C at this point. DTT is added 
to 2X reaction buffer (10µl DTT per mL 2X reaction buffer) immediately before use. 50 μL of 
reaction buffer mix is added to each of the samples. 5 μL of the 1 mM DEVD-AFC substrate is 
then added to each sample. The samples are incubated at 37°C for 1-2 hours. The samples are 
read on a fluorometer at an excitation of 355 nm and an emission of 520 nm. 
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3.8 CASPASE-3 FLUORESCENT ASSAY IN TISSUES  
Rabbits were serially sacrificed after being infected with SCHU S4. The rabbit tissues 
were harvested and frozen at -80°C. The frozen tissues were thawed and cut into 0.03-0.05 g 
pieces. The tissues were homogenized in 1 mL chilled cell lysis buffer. The samples were 
incubated for 10 minutes. Samples were pelleted by centrifugation at 20000xg for 2-5 minutes. 
The supernatant was transferred to a clean tube. The samples can be frozen at -80°C at this point. 
50 µl of each sample is transferred to a well in a 96-well plate. DTT is added to the 2X reaction 
buffer immediately before use. 50 µl of the reaction buffer mix is added to each well. 5µl of 
DEVD-AFC substrate is added to each well. The plate is incubated (protected from light) for 1-2 
hours at 37°C. The samples are read on a fluorometer at an excitation of 355 nm and an emission 
of 520 nm. 
3.9 CASPASE-1 FLUORESCENT ASSAY IN CELL CULTURES 
This protocol is adopted from the Abcam Caspase 1 Assay Kit manual (ab39412). The 
infection assay will be performed as described above until the lysing step. The cells will be 
harvested by adding 100 µl trypsin to each well. After the cells detach from the plate, 900 µl of 
DMEM-10 without antibiotics is added. The cells are pelleted by centrifugation at 6000xg for 5 
minutes. The cells are washed with PBS, counted and 1-5 x 106 cells are pelleted by 
centrifugation. The pellet is resuspended in 50 μL of chilled Cell Lysis Buffer (Abcam). The 
solution is incubated on ice for 10 minutes. The samples can be frozen at -80°C at this point. 
DTT (Abcam) is added to 2X reaction buffer (10µl DTT per mL 2X reaction buffer) immediately 
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before use. 50 μL of reaction buffer mix is added to each of the samples. 5 μL of the 1 mM 
YVAD-AFC substrate (Abcam) is then added to each sample. The samples are incubated at 37°C 
for 1-2 hours (protected from light). The samples are read on a fluorometer at an excitation of 
355 nm and an emission of 520 nm. 
3.10 CASPASE-1 FLUORESCENT ASSAY IN TISSUES 
This protocol is adopted from the Abcam Caspase 1 Assay Kit manual (ab39412). The 
infection assay will be performed as described above until the lysing step. The cells will be 
harvested by adding 100 µl trypsin to each well. After the cells detach from the plate, 900 µl of 
DMEM-10 without antibiotics is added. The cells are pelleted by centrifugation at 6000xg for 5 
minutes. The cells are washed with PBS, counted and 1-5 x 106 cells are pelleted by 
centrifugation. The pellet is resuspended in 50 μL of chilled Cell Lysis Buffer (Abcam). The 
solution is incubated on ice for 10 minutes. The samples can be frozen at -80°C at this point. 
DTT (Abcam) is added to 2X reaction buffer (10µl DTT per ml 2X reaction buffer) immediately 
before use. 50 μL of reaction buffer mix is added to each of the samples. 5 μL of the 1 mM 
YVAD-AFC substrate (Abcam) is then added to each sample. The samples are incubated at 37°C 
for 1-2 hours. The samples are read on a fluorometer at an excitation of 355 nm and an emission 
of 520 nm. 
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3.11 HEMATOXYLIN AND EOSIN STAINING 
The first three steps of this protocol were performed by dipping the slide in xylene for 3 
minutes each time. These steps removed the paraffin on the slides. The next four steps were 
varying percentages of ethanol (100, 100, 95 and 70). These steps were a minute a piece. The 
next two steps were one-minute wash steps. The next step was the hematoxylin staining step. 
The slides were placed in hematoxylin for three minutes. There were two thirty second wash 
steps. The slide was immersed in acid alcohol for thirty-five seconds. There were two thirty 
second wash steps. The next step was the bluing step with Scott’s tap water for thirty seconds. 
There were two one-minute wash steps. Next was the eosin staining step (2 minutes). The next 
four steps are the dehydrating steps with the same ethanol used above in reverse order. The last 
three steps are one-minute xylene steps.  
3.12 TUNEL ASSAY 
The Invitrogen Click-iT TUNEL Colorimetric IHC Detection Kit was used. First, the 
cells were deparaffinized by placing slides in xylene twice for five minutes, 1:1 xylene:100% 
ethanol for five minutes, 100% ethanol for 5 minutes then 3 minutes, 95% ethanol for 3 minutes, 
85% ethanol for 3 minutes, 75% ethanol for 3 minutes, 50% ethanol for 3 minutes, 0.85% NaCl 
for five minutes and then 1X PBS for 5 minutes. Proteinase K (Invitrogen) was added so that the 
whole tissue was covered. Samples were incubated for 10-20 minutes at room temperature. The 
slides were washed by immersing in PBS for five minutes. The slides were immersed in fixative 
solution for five minutes at room temperature. The slides were rinsed with PBS then washed by 
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immersion in PBS for five minutes twice. The slides were rinsed with deionized water. 100 µl of 
TdT Reaction Buffer (Invitrogen) was added to each slide (covering the whole tissue). The slides 
were incubated for 10 minutes at 37°C. The TdT Reaction Mixture (Invitrogen) was prepared by 
adding 558µl TdT Reaction Buffer (Invitrogen), 10µl EdUTP (Invitrogen), and 30µl TdT 
Enzyme (Invitrogen). The TdT Reaction Buffer (Invitrogen) was removed by blotting with a 
Kimwipe. 50µl of the TdT Reaction Mixture (Invitrogen) was added to each slide. The slides 
were incubated for one hour at 37°C. The slides were rinsed with PBS and immersed in 2X SSC 
for fifteen minutes. The slides were washed twice by immersing them in PBS for five minutes. 
The slides were immersed in 3% hydrogen peroxide for five minutes at room temperature. The 
slides were washed twice by immersion in PBS for five minutes. The slides were washed twice 
with 1X Click-iT TUNEL Colorimetric Wash solution (Invitrogen) for five minutes. The 1X 
Click-iT TUNEL Reaction Buffer Additive (Invitrogen) working solution was prepared by 
diluting the solution 1:10 in deionized water. The Click-iT TUNEL Colorimetric Cocktail was 
prepared by adding 510µl 1X Click-iT Reaction Buffer (Invitrogen), 24µl CuSO4 (Invitrogen), 
6µl Biotin Azide (Invitrogen), and 60µl 1X Click-iT Reaction Buffer Additive working solution. 
50 µl of the Click-iT TUNEL Colorimetric Reaction Cocktail was added to each slide. The slides 
were incubated protected from light for 30 minutes at 37°C. The slides were rinsed with PBS 
then washed twice with the 1X Click-iT TUNEL Colorimetric Wash solution (Invitrogen) for 5 
minutes. The slides were rinsed with deionized water then about 200 µl of 1X Streptavidin-
Peroxidase Conjugate (Invitrogen) was added to each slide. The slides were incubated at room 
temperature for 30 minutes. The slides were washed three times for 5 minutes with PBS. The 
slides were rinsed with deionized water and excess water was removed. 5 µl of DAB Chromogen 
(Invitrogen) was added to 95 µl DAB substrate buffer for each slide. The 100 µl was added to 
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each slide and incubated for a maximum of 10 minutes at room temperature. The slides were 
washed thoroughly with deionized water. Slides were counterstained with methyl green. 0.05% 
methyl green solution was made in sodium acetate. Slides were washed in distilled water after 
staining. Slides were immersed in methyl green solution for five minutes. The slides were rinsed 
with distilled water. Next, the slides were dehydrated by immersion in 95% ethanol 10 times. 
The slides were dipped in 100% ethanol 10 times. That step was repeated. The slides were 
cleared by immersion in xylene.  
3.13 SLIDE CUTTING 
Slides were cut on a microtome. Tissue blocks were placed on the microtome. The blade 
was changed to ensure clean cuts. The blade was pushed up against the block and locked into 
place. The wheel was rotated to move the block up and down. Sections were cut at 5 microns. As 
the sections came off in ribbons, the ribbons were carefully placed on top of warm water. The 
sections of the ribbons were separated by gently poking holes in the wax as it warmed. A clean 
glass slide was angled in the water under each section and carefully moved upward to “catch” the 
section on the slide. Slides were placed at an angle to allow water to run off and then incubated 
overnight at 57°C.  
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3.14 LUNG DIGEST 
First, a piece of lung tissue was weighed and placed in a petri dish. The piece was minced 
with scissors into 1 cm pieces. The lung pieces were placed in a 50 ml conical with 25 ml 
digestion media. The tubes were placed in a 37°C water bath for 45-60 minutes. After 
incubation, the pieces were transferred back to the petri dish. The pieces were mashed with a 5 
ml syringe plunger and washed with HBSS-Hepes-DNaseI. The tissue was mashed carefully, to 
prevent it from becoming slimy. The liquid was run through a 70µm cell strainer sitting in a 50 
ml conical. The tubes were centrifuged at 600xg for 10 minutes. The supernatant was removed 
and placed in Oakridge tubes. The Oakridge tubes were centrifuged at 4000xg for 10 minutes to 
get free bacteria. The pellet was resuspended in 20 ml of PBS, dilutions were made and plated on 
CHA. The pellet remaining after the supernatant was moved to Oakridge tubes is resuspended in 
10 ml of ACK lysing buffer. The ACK mixture was incubated for 5-10 minutes at room 
temperature. After incubation, the total volume was brought up to 50 ml with PBS. The tubes 
were centrifuged at 600xg for 10 minutes at 4°C. The supernatant was removed, and the pellet 
was washed with 30-40 ml of MACs buffer. The tubes were centrifuged at 600 xg for 10 minutes 
at 4°C. The supernatant was removed, and cells were resuspended in 1 ml of freezing media 
(90% FBS and 10% DMSO) and frozen at -80°C.  
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4.0  IN VITRO MODEL OF INFECTION 
The first aim of this project was to determine whether F. tularensis could infect human 
primary lung epithelial cells at an air-liquid interface and to compare that with conventional in 
vitro infection of A549 cells, a transformed human lung epithelial cell line, and J774 cells, a 
transformed murine macrophage cell line that is commonly used with F. tularensis. Three strains 
of F. tularensis were used: U112, LVS, and SCHU S4. Overall, this aim focuses on the ability of 
F. tularensis to infect and replicate in these cells. 
4.1.1 Initial Infection Assays 
First, the infection assay was performed using J774 cells only. Next, I compared the 
ability of F. tularensis to infect and replicate in A549 cells to that of infection in J774 cells. For 
the initial assays, J774 (a mouse macrophage cell line) and A549 (a human alveolar epithelial 
cell line) were infected with one of three strains of F. tularensis (U112, LVS, SCHU S4). U112, 
LVS and SCHU S4 have been used in experiments individually and occasionally two have been 
compared; however, the goal of this experiment was to demonstrate whether infection and 
replication in lung epithelium had a role in virulence of the different strains. Although the 
infections were performed on separate days, the same passage of eukaryotic cell stocks were 
used for all the assays with a target multiplicity of infection (MOI) of 100. The actual MOIs for 
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the three infections were slightly higher than the target of 100. The LVS infection had an MOI of 
106. The U112 infection had an MOI of 119. The SCHU S4 infection had an MOI of 131 based 
on the bacterial inoculum that was plated (Table 1). Unfortunately, some time points had cells in 
a nonquantifiable range. Also, there was no growth at several time points for SCHU S4 and LVS, 
so the data is not shown.   










U112 A549 5.58 119 3150 0.0070 
U112 J774 5.58 119 2131 0.0047 
LVS A549 5.58 133 200 0.0004 
LVS J774 5.58 133 
SCHU S4 A549 5.58 165 2113 0.0034 
SCHU S4 J774 5.58 165 1163 0.0019 
J774 and A549 cells were infected with U112, LVS and SCHU S4. The number of cells plated 24 hours pre-
infection, MOI calculated by dividing the CFU by the number of cells plated, CFU at time 0 and infection 
efficiency. The CFU at 0 HPI and infection efficiency are blank for J774 cells infected with LVS because no 
colonies grew on the 0 HPI CHA plates. Infection efficiency is calculated by dividing the CFU at 0 HPI by the MOI 
times number of cells (300,000). 
Since there were missing time points from the first assay, the assay was performed again 
with just the J774 cells. Again, the target MOI was 100. However, the MOI for U112 and LVS 
assays was 70 and the MOI for the SCHU S4 assay was lower at 48 (Table 2). In the previous 
experiment, there were 380,000 cells/well. In this experiment, there were only 300,000 
cells/well. Therefore, there would be less cell-to-cell interaction, which could impact cell-to-cell 
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infection. There was data for every time point and strain of F. tularensis (Figure 1). The U112 
and SCHU S4 counts increased at every time point, which was not expected based on published 
results and previous experiments in the laboratory. Whereas, the LVS counts increased between 
0 and 24 HPI, but remained steady through 72 HPI (Figure 1). Typically, the colony counts peak 
at 24 or 48 HPI and drop at 72 HPI. 
    Table 2. J774 Infection Assay. 
Strain Cell Type Eukaryotic 
Cells (log10) 





U112 J774 5.48 150 967 0.0021 
LVS J774 5.48 100 1717 0.0057 
SCHU S4 J774 5.48 103 2750 0.0089 
J774 infection assay with U112, LVS and SCHU S4. The number of cells plated 24 pre-infection, MOI, CFU at 
Time 0, and infection efficiency are shown. Infection efficiency is calculated by dividing the CFU at 0 HPI by the 
inoculum. 
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Figure 1. J774 Infection Assay. 
J774 cells infected with U112, LVS and SCHU S4. Lysate was serially diluted and plated on CHA quad plates. 
Colonies were counted 48 hours later. Doubling rates at 24, 48 and 72 (left) hours and colony counts at 0, 24, 48 and 
72 HPI (right) are shown. Samples were performed in triplicate. Means and ranges are shown.  
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Next the same assay as above was performed with A549 cells only. The MOIs for this 
assay were lower than previously at 42, 78 and 20 for U112, LVS and SCHU S4 respectively 
(Table 3). Again, the U112 counts increased at every time point. Nothing grew for SCHU S4 at 
24 HPI, but the counts increased at both 48 and 72 HPI. There was no growth on the plates for 
the LVS infection at 0, 24 or 72 HPI (Figure 2). This may be a result of not mixing the inoculum 
well enough before adding it to each well. Also, the lysate may not have been mixed well before 
making the dilutions or the bacteria could have been lysed as well. During this assay, the 
supernatant was plated on CHA at the 24 HPI. There was growth on the U112 plate. Therefore, 
the gentamicin might not have been killing all the extracellular bacteria. Consequently, the 
results from these three assays cannot be described as intracellular spread from cell-to-cell only. 
This could be important because cell-to-cell spread could be a way of evading the immune 
system in the host.  
   Table 3. A549 Infection Assay 1. 
Strain Cell Type Eukaryotic 
Cells (log10) 





U112 A549 5.58 42 540 0.0034 
LVS A549 5.58 78 
SCHU S4 A549 5.58 20 47 0.0006 
A549 cells were infected with U112, LVS and SCHU S4. The number of cells plated 24 hours pre-infection, MOI, 
CFU at 0 HPI and infection efficiency are shown below. Infection efficiency is calculated by dividing the CFU at 0 
HPI by the inoculum. 
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Figure 2. A549 Infection Assay 1. 
A549 cells infected with U112, LVS and SCHU S4. Lysate was serially diluted and plated on CHA quad plates. 
Colonies were counted 48 hours later. Doubling rates at 24, 48 and 72 (left) hours and colony counts at 0, 24, 48 and 
72 HPI (right) are shown. Samples were performed in triplicate. Means and ranges are shown. 
4.1.2 Lung Epithelial Cell Infection 
Since there were issues with getting results at each timepoint, I decided to focus on 
infecting the A549 cell line with SCHU S4 and LVS, but not U112. The infection assay was 
performed as previously described with new gentamicin. Eight infection assays were performed 
at once. Two of the infection assays were used to collect data on colony counts and doubling 
rates. The remaining assays were used to collect samples for the caspase-1 and caspase-3 assays. 
To improve the assay protocol, during the lysing step the pipet tip was used to break up the A549 
layer. The tip was moved in concentric circles around the wells and the in a cross motion to 
improve the lysing process. This was especially necessary at the 48 and 72 HPI timepoints 
because the epithelial cells were more confluent at these timepoints.  
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Table 4. A549 Infection Assay 2. 
Strain Cell Type Eukaryotic 
Cells (log10) 




SCHU S4 A549 5.48 61.7 3050 0.0165 
LVS A549 5.48 68.3 250 0.0012 
A549 cells were infected with LVS and SCHU S4. The number of cells plated 24 hours pre-infection, MOI, CFU at 
0 HPI and infection efficiency are shown below. Infection efficiency is calculated by dividing the CFU at 0 HPI by 
the inoculum. 
Although the OD predicted the MOI would be 100, the MOIs ended up being 62 and 68 
bacteria per eukaryotic cell. This assay had exactly 300,000 cells in each well. At timepoint zero, 
the average number of LVS that were able to infect the cells was 93. While, over 2500 SCHU S4 
bacteria were able to infect the cells. The infection efficiencies for both bacteria are extremely 
low at below one percent (Table 4). Both the LVS and the SCHU S4 followed the predicted 
growth rates and doubling. SCHU S4 peaked at 24 HPI and LVS peaked at 48 HPI (Figure 3).  
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Figure 3. A549 Infection Assay 2. 
A549 cells were infected with LVS and SCHU S4. Lysate was serially diluted and plated on CHA quad plates. 
Colonies were counted 48 hours later. Doubling rates at 24, 48 and 72 (left) hours and colony counts at 0, 24, 48 and 
72 HPI (right) are shown. Only two wells of LVS had growth at 0 HPI, therefore LVS 0 HPI is the average of two 
wells and all LVS doubling rate are an average of two wells. All SCHU S4 data is the average of three wells. Means 
and ranges are shown.   
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The assay was repeated for reproducibility. The MOIs were higher for LVS and SCHU 
S4 compared to the previous assay (Table 5). However, both strains had lower CFU at 0 HPI. 
The growth rates for SCHU S4 peaked at 48 HPI as compared to 24 HPI. The doubling rates 
from both experiments follow the same pattern. LVS peaked at 48 HPI in both infection assays; 
however, it had high replication rates in the second infection assay. Overall, these data suggest 
that LVS and SCHU S4 have similar growth and doubling rates in A549 cells (Figure 4). 
However, SCHU S4 typically had a higher capacity to infect than LVS initially. The differences 
seen in the infection assays could be due to the bacteria used. While the initial loopfuls came 
from the same aliquot, the bacteria do not always recover the same from being thawed. 
Alternatively, it could just be experimental variation.  
  Table 5. A549 Infection Assay 3. 
Strain Cell Type Eukaryotic Cells 
(log10) 




SCHU S4 A549 5.48 66.7 467 0.0023 
LVS A549 5.48 86.7 123 0.0005 
A549 cells were infected with LVS and SCHU S4. The number of cells plated 24 hours pre-infection, MOI, CFU at 
0 HPI and infection efficiency are shown below. Infection efficiency is calculated by dividing the CFU at 0 HPI by 
the inoculum. 
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Figure 4. A549 Infection Assay 3. 
A549 cells infected with LVS and SCHU S4. Lysate was serially diluted and plated on CHA quad plates. Colonies 
were counted 48 hours later. Doubling rates at 24, 48 and 72 (left) hours and colony counts at 0, 24, 48 and 72 HPI 
(right) are shown. Samples were performed in triplicate. Means and ranges are shown. 
A549 cells were infected with SCHU S4 as previously described. Cells were lysed and 
the caspase levels were assessed using fluorescence. The plates were supposed to be read at 
400/505nm; however, the machine was unable to read at these wavelengths. The plates were read 
at 355/520nm. There were no significant differences in the fluorescence between timepoint and 
uninfected controls (Figure 5).  
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Figure 5. A549 Caspase-1 and Caspase-3. 
A549 cells were infected with SCHU S4. Cells were lysed and caspase levels were assessed. No difference in 
fluorescence levels was seen. Samples were performed in triplicate. Means and ranges are shown. 
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4.1.3 Human Primary Lung Infection 
The protocol used in the previously mentioned experiments was used to develop an 
infection assay for a 3D culture of human primary lung epithelium. These cultures are designed 
to mimic the structure of the epithelium in the human lung. These cells develop cilia, produce 
mucous and are polarized. The human bronchial epithelium was provided by Mike Myerburg’s 
lab (Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, 
Department of Medicine). The cells were obtained from his lab, washed to remove antibiotics 
and antibiotic free media was added. The first infection assays were performed with LVS only. 
The bacterial inoculum was created by adding a loopful of bacteria to PBS. The target MOI for 
the first assay was 10. 10 µl of bacterial inoculum was added to each well (Table 6). The cells 
were incubated for three hours at 30°C and 5% CO2. At the end of the incubation, PBS was 
added to the top. The liquid was removed, diluted and plated. The cells were then washed several 
times with PBS. The cells were lysed using 0.02% SDS. However, this would not lyse the cells. 
Sterile water was also used to try to lyse cells and it did not work as well. The 0.02% SDS was 
used again in combination with pipetting up and down which eventually lysed the cells. The cell 
lysate was diluted and plated. The media from the bottom of the wells was also diluted and 
plated. The idea was to see where the bacteria was: still on top of the cells, in the cells or through 
the cells. There was no growth on almost all the plates. There was growth for 1/6 of the top layer 
sets of plates (Table 6). From this infection assay, it was concluded that the MOI, infection time 
and amount of bacterial inoculum plated may influence the assay. The cells used for this assay 
came from a donor with silicosis. This could have influenced the cells susceptibility to F. 
tularensis.  
33 
Table 6. HBE Infection Assay 1. 
MOI Amount 
Plated 
Incubation 0 HPI Counts 24 HPI 
Counts 
Cell ID Disease 
19.5 10 µl 2 Hours All 0/0 except one top All 0/0 191 Silicosis 
HBE cells from a donor with silicosis were infected with LVS at an MOI of 19.5. 10 µl of inoculum were plated 
onto the cells. There was no LVS in the cell lysate and media at 0 HPI. One out of six wells of HBE cells had LVS 
growth in the inoculum wash at 0 HPI. There was no LVS in the cell lysate, media, or inoculum wash at 24 HPI. 
To address some of the possible issues from the first assay, another infection assay was 
performed. Different MOIs, incubation times and inoculum plated were tested (Tables 7 and 8). 
Cells from a healthy donor were used for this assay. This time only the cell lysate was diluted 
and plated. The cells were also lysed differently this time. The 0.02% SDS is added to each well 
and the pipette tip is used to scrape the cells of the film. This action also helps lyse the cells. 
Again, there was no growth on any of the plates (Table 8). Therefore, the question became: can 
Francisella even infect primary human lung epithelium?   





































HBE cells were infected with 50-100 µl of LVS inoculum at target MOI of 100 or 10. The cells were incubated with 
the inoculum from 2 to 3 hours.  
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                  Table 8. HBE Infection Assay 2. 
Amount Plated MOI Cell ID Disease 0 HPI Counts 
100 µl 160 195 None All 0/0 
50 µl 322.5 195 None All 0/0 
50 µl 27.25 195 None All 0/0 
HBE cells from a healthy donor were infected with LVS at MOIs from 27.25-322.5. Inoculum was plated in 50-100 
µl amounts. There was no growth in the cell lysate at 24 HPI.  
To address this question the assay was repeated using 50 µl and MOI of 10 (Table 9). 
Again, the cells were from a healthy donor. However, only a 24-hour timepoint was plated. Also, 
the cells were infected with SCHU S4 and LVS to determine if there is a strain difference in 
infection. There was growth on both the LVS and SCHU S4 plates (Figure 6). This suggests that 
F. tularensis can infect primary human bronchial epithelium.
             Table 9. HBE Infection Assay 3. 
Strain Amount Plated MOI Cell ID Disease 
LVS 50 µl 7 190 None 
SCHU S4 50 µl 12.25 190 None 
HBE cells from a healthy donor were infected with two strains of F. tularensis: LVS and SCHU S4 at MOIs from 7-
12.25. The inoculum was plated in 50 µl amounts.  
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Figure 6. LVS and SCHU S4 colony counts in HBE cell lysate 24 hours post-infection. 
HBE cells from a healthy donor were infected with LVS and SCHU S4. There was no growth at 0 HPI. The CFU/ml 
lysate are shown. Samples were performed in triplicate. Means and ranges are shown. 
The assay was repeated to confirm results; however, there was inconsistency in the 
results. The cells used for this assay were from a donor with silicosis. The MOIs were similar to 
the MOIs in the previous assay (Table 10). There was growth at 24 HPI (Figure 7), but there was 
no growth at 0, 48, 72, or 96 HPI (Table 10). It was suggested that using PBS could be impacting 
the bacteria’s ability to survive in the inoculum. 
Table 10. HBE Infection Assay 4. 








LVS 8 191 Silicosis 0/0 0/0 0/0 0/0 
SCHU S4 12.25 191 Silicosis 0/0 0/0 0/0 0/0 
HBE cells from a donor with silicosis were infected with LVS and SCHU S4 at MOIs from 8-12.25. There was no 
growth on the 0 HPI and 48 HPI plates. The PBS used for 72 and 96 HPI dilutions was contaminated, but there was 
no growth from the lysate.  
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Figure 7. HBE Infection Assay 4. 
HBE cells from a donor with silicosis were infected with LVS and SCHU S4. There was growth at 24 HPI for both 
the LVS and SCHU S4 infected cells. Samples were performed in triplicate. Means and ranges are shown. 
Another assay was performed using BHI and PBS for the inoculum. Francisella grows 
well in BHI, so if PBS was the problem, the results should have been more consistent. The MOIs 
were slightly lower than previous assays. The cells used for this assay were from a healthy donor 
(Table 11). However, again the results were inconsistent (Figure 8). The colony counts ranged 
from 2-60 within the replicate wells. There could be several explanations for the inconsistent 
results. First, cells from different donors were used for each assay. While the cells were from 
different donors, the results should still be consistent when compared to that same patient and 
this was not true. Therefore, that explanation seemed unlikely. Second, some of the CHA plates 
used in the last assay were dry and bumpy by the time the plates were counted. However, there 
was growth on some of the dry and bumpy plates. Finally, the assay protocol did not use 
antibiotics to kill the extracellular bacteria before lysing. Therefore, some extracellular bacteria 
may have been trapped in the cilia or mucous causing the higher colony counts. This seemed to 
be the most likely cause of inconsistency. To address this issue, several steps were added to the 
assay protocol. A DTT rinse was added to remove the mucous layer before infection to allow the 
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bacteria to access the cells easier. Also, a thirty-minute incubation with PBS with 50 µg/ml 
gentamicin was added. The wells were washed three times after to remove all the gentamicin. 
The last washing step was plated to confirm that all of the extracellular bacteria were killed with 
the gentamicin.  
Table 11. HBE Infection Assay 5. 
Strain Media MOI Cell ID Disease 
SCHU S4 PBS 7.25 190 None 
SCHU S4 BHI 7.75 190 None 
HBE cells from a healthy donor were infected with SCHU S4 at MOIs from 7.25-7.75. The inoculum was prepared 
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Figure 8. HBE Infection Assay 5. 
There was growth in the HBE lysate at 0 and 24 HPI. The counts were inconsistent within the replicate wells. 
Samples were performed in triplicate. Means and ranges are shown. 
Cells from a donor with bronchopulmonary dysplasia and another donor with 
scleroderma and pulmonary arterial hypertension were used for this assay. The MOIs were 
higher than previous assays (Table 12). The additions to the protocol did not kill or remove all 
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the extracellular bacteria in the wells. All the last wash plates had colonies (Table 12). There was 
growth at 0 and 24 HPI (Figure 9). The quantity of intracellular bacteria could not be quantified 
due to the presence of bacteria in the last wash. 
Table 12. HBE Infection Assay 6. 
MOI Cell ID Disease 0 HPI Wash 24 HPI Wash 
15 197 Bronchopulmonary dysplasia Positive Positive 
15 199 Scleroderma/Pulmonary arterial hypertension Positive Positive 
HBE cells from a donor with bronchopulmonary dysplasia and another with scleroderma and pulmonary arterial 

















Figure 9. HBE Infection Assay 6. 
Lysate from both HBE cell lines contained SCHU S4 at 0 HPI and 24 HPI. Samples were performed in triplicate. 
Means and ranges are shown. 
The gentamicin step is an hour for the A549 cells, so the gentamicin incubation time for 
the HBE cells was increased to an hour. Also, 900 µl of PBS was added to the 100 µl of last 
wash, dilutions were made and plated. The last wash CFU were subtracted from the lysate CFU 
to predict the number of intracellular bacteria. This assay was performed with cells from a donor 
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with bronchopulmonary dysplasia and another donor with scleroderma and pulmonary arterial 
hypertension. The MOIs were lower than the previous assay (Table 13). There was growth in the 
last wash and lysate; however, the growth in the lysate was higher than the last wash (Figure 10). 
I concluded that F. tularensis can infect HBE cells.  
Table 13. HBE Infection Assay 7. 
MOI Cell ID Disease 
6.75 197 Bronchopulmonary dyslplasia 
6.75 199 Scleroderma/Pulmonary arterial hypertension 
HBE cells from a donor with bronchopulmonary dysplasia and another with scleroderma and pulmonary arterial 
hypertension were infected with SCHU S4 at a MOI of 6.75. 
The assay was performed again for reproducibility with the cells from the donor with 
bronchopulmonary dysplasia. The MOI was higher than the previous assay, which may explain 
the higher wash and lysate counts (Table 14). Again, there was growth in the lysate and last wash 
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Figure 10. HBE Infection Assay 7. 
Colony counts from last wash (top right) were subtracted from colony counts from cell lysate (top left). The results 
are shown (bottom). There are more colonies in the lysate than in the wash proving that SCHU S4 is infecting the 
HBE cells. Samples were performed in triplicate. Means and ranges are shown. 
                                Table 14. HBE Infection Assay 8. 
MOI Cell ID Disease 
15 197 Bronchopulmonary dysplasia 
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Figure 11. HBE Infection Assay 8. 
Colony counts from last wash (top right) were subtracted from colony counts from cell lysate (top left). The results 
are shown (bottom). There are more colonies in the lysate than in the wash proving that SCHU S4 is infecting the 
HBE cells. Samples were performed in triplicate. Means and ranges are shown. 
4.2 PATHOGENESIS IN RABBIT LUNGS 
Rabbit tissues from a previous study were used. There were 12 rabbits in this study. 
Three rabbits were not infected before they were sacrificed. The remaining rabbits were serially 
sacrificed one, two and three days post exposure. There were three rabbits sacrificed at each time 
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point. At the time of sacrifice, the bronchoalveolar lavage was taken to determine presence of 
Francisella. The lungs from eight out of the nine infected rabbits’ lungs were digested. Some of 
the lung digest was serially diluted and plated on CHA plates to determine the presence of 
bacteria. The remaining tissues were harvest and frozen at -80°C. The lower left lung sections 
were homogenized later. Homogenate was plated to determine presence of bacteria. Also, the 
homogenate was lysed for caspase-1 and caspase-3 assays. There were three uninfected rabbits in 
this study; however, they were sacrificed differently than the infected rabbits. Also, there were 
positive colony counts for all three in the lower left lung of all three uninfected rabbits. 
Therefore, the controls were not used for the caspase and TUNEL staining. There were no other 
uninfected rabbit tissues to use as controls. More uninfected rabbits will have to be sacrificed for 
controls in the future. 
All infected rabbits received similar doses during the aerosol. The rabbits sacrificed three 
days post-exposure had slightly higher doses than the other rabbits. Bronchoalveolar lavage 
(BAL) was taken at time of necropsy. The BAL increased with each day post-exposure. The lung 
digest and homogenate colony counts peaked at day two post-exposure (Figure 12). Typically, 
unvaccinated rabbits develop fevers around day three post-exposure. The rabbits in this study 
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Figure 12. Francisella tularensis in Rabbit Lung Tissue. 
Lung tissue from rabbits sacrificed one, two and three days post-exposure was digested and titers were plated. 
Frozen lower left lung tissue was homogenized and titers were plated. Both homogenate and lung digest CFU/g 
peaked two days post-exposure. BALs were performed on rabbits during the necropsy. The CFU in the BAL 
increased with each day post-exposure. Mean and ranges are shown.  
4.2.1 Caspase Assays 
For the caspase assays the frozen tissues were thawed, weighed and homogenized in 
chilled cell lysis buffer. The samples were frozen and the assay was performed later. The plates 
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were supposed to be read at excitation/emission: 400/505 nm; however, the plate reader was 
unable to read at these wavelengths. Therefore, the first plates were read at 355/520 nm. There 
were no significant caspase differences in the infected and uninfected rabbit tissues. There were 
slightly higher caspase-1 levels in the rabbits sacrificed one day post-exposure. There were 
slightly higher caspase-3 levels in the rabbits sacrificed one day and three days post-exposure 
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Figure 13. Rabbit Caspase Staining. 
The presence of caspase-1 and caspase-3 in lower left lung homogenate from rabbits sacrificed one, two and three 
days post-exposure. There does not appear to be any difference in the caspase levels in the infected and uninfected 
rabbits.  
4.2.2 Lung Slides 
Sections of the lungs of the rabbits were also paraffin-embedded and cut onto slides. 
Each rabbit tissue had a slide stained with H&E and a slide stained with TUNEL. Two of the 
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rabbits sacrificed one day post-exposure had healthy, uninflamed lungs. However, one showed 
evidence of some inflammation and hemorrhaging (Figure 14). One rabbit sacrificed two days 
post-exposure had a high amount of inflammation and hemorrhaging. The other rabbit showed 
no evidence of inflammation or hemorrhaging. Also, one rabbit sacrificed three days post-
exposure had a high amount of inflammation and hemorrhaging, while the other appeared to 
have healthy lungs (Figure 14).  
Figure 14. Inflammation in the lower left lung of rabbits sacrificed one to three days post-exposure to SCHU-
S4. 
Lower left lung tissue from rabbits sacrificed one (A-D), two (E-G) and three (H-I) days post-exposure were stained 
with hematoxylin and eosin. Images were taken at 10x magnification. Inflammation and hemorrhaging increases 
each day post-exposure.  
The slides were TUNEL stained as well. There is a small amount of DNA fragmentation 
in one of the rabbits sacrificed one day post-exposure. There is more DNA fragmentation in the 
rabbits sacrificed two days post-exposure. There is a higher amount of DNA fragmentation, 
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suggesting apoptosis, in the rabbits sacrificed three days post-exposure than the two days prior 
(Figure 15).  
Figure 15. DNA fragmentation in the lower left lung of rabbits sacrificed one to three days post-exposure to 
SCHU-S4. 
Lower left lung from rabbits sacrificed one (A-B), two (C-D) and three (E-F) days post-exposure were TUNEL 
stained. Images were taken at 10x magnification. The DNA fragmentation levels appear to increase each day post-
exposure. Although, the DNA fragmentation is present the level of DNA fragmentation is not high. There is some 
background seen on the slides (C).  
To confirm these results, slides from the upper right lung were cut. Also, lung tissue from 
rabbits sacrificed four and five days post-exposure were cut. The inflammation varied throughout 
each tissue sample, but it increased each day post-exposure (Figure 16). Specifically, the tissue 
from the rabbits sacrificed four days post-exposure showed extremely high levels of 
inflammation. There were almost no alveolar regions throughout the tissue. Edema can be seen 
in the tissues from the rabbits sacrificed five days post-exposure (Figure 18).  
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Figure 16. Inflammation in the upper right lung rabbits sacrificed one to three days post-exposure to SCHU-
S4. 
Upper right lung tissue from rabbits sacrificed one (A-D), two (E-H) and three (I-N) days post-exposure were 
stained with hematoxylin and eosin. Images are in pairs from the same rabbit to show varying levels of inflammation 
within the sections. Images were taken at 10x magnification. The most inflammation and hemorrhaging were seen in 
the rabbits sacrificed three days post-exposure.  
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Figure 17. DNA fragmentation in upper right lung of rabbits sacrificed one to three days post-exposure to 
SCHU-S4.  
Upper right lung tissue from rabbits sacrificed one (A-C), two (D-H) and three (I-L) days post-exposure were 
TUNEL stained. Images were taken at 10x magnification. The DNA fragmentation levels appear to increase each 
day post-exposure. Although, the DNA fragmentation is present the level of DNA fragmentation is not high. There 
was high background on most slides and control slides (not shown).   
The slides were also TUNEL stained. There appears to be increasing amounts of DNA 
fragmentation in the tissues (Figure 17). There were high levels of background on the control 
slide and several of the other slides. The background makes it difficult to definitively say there is 
TUNEL positive staining. The highest levels of TUNEL positive staining were seen in one rabbit 
sacrificed four days post-exposure and one sacrificed five days post-exposure (Figure 19). There 
were nodules in some of the rabbit tissues. These nodules stained TUNEL positive in the rabbit 
lung tissue from the rabbits sacrificed four days post-exposure (Figure 19). 
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Figure 18. Inflammation in the lung of rabbits sacrificed four and five days post-exposure to SCHU S4. 
Lung tissue from rabbits sacrificed four (A-F) and five (G-L) days post-exposure were stained with hematoxylin and 
eosin. Images are in triplicate from the same rabbit. Images were taken at 10x magnification. The most inflammation 
was seen in the rabbits sacrificed four days post-exposure (D-F).  
50 
Figure 19. DNA fragmentation in lung tissue from rabbits sacrificed four and five days post-exposure to 
SCHU S4. 
Lung tissue from rabbits sacrificed four (A-F) and five (G-L) days post-exposure were TUNEL stained. Images were 
taken at 10x magnification except image F. F was taken at 5x magnification. The DNA fragmentation levels vary 
between rabbits. The levels are higher in one rabbits sacrificed four days post-exposure (A-C) and five days post-
exposure (J-L) than the rabbits sacrificed one to three days post-exposure (shown previously). 
Overall, it appears that cell death and inflammation increased from one to four days post-
exposure to SCHU S4. The inflammation was slightly decreased in the rabbits sacrificed five 
days post-exposure. The hemorrhaging increased from one to three days post-exposure in the 
lung tissues. In the future, the results will be compared to new uninfected controls that were 
sacrificed the same way and do not have bacteria in the lungs.  
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5.0  DISCUSSION 
Previous groups have studied the cell types infected by Francisella in the lungs of mice. 
They found that U112, LVS and SCHU S4 strains of Francisella were able to infect alveolar 
macrophages, CD11bhigh macrophages, CD11blow/mid dendritic cells, CD11bhigh dendritic cells, 
monocytes, neutrophils and alveolar type II epithelial cells. Not surprisingly, they found that one 
day post-infection that alveolar macrophages composed most infected cells for all three strains. 
Both the macrophages and alveolar type II epithelial cells had higher numbers of infected cells at 
one day post-infection when compared to three days post-infection [24]. The bacteria must peak 
between 24 and 48 HPI. Therefore, I expected to see similar results with our in vitro work. I 
found the growth rates peaked at 24 or 48 hours post-infection, indicating my in vitro work is 
consistent with the published in vivo studies. F. tularensis disseminates quickly through the 
body; therefore, by day three the bacteria are likely disseminating throughout the body and no 
longer needs to replicate at high levels in the epithelial cells.  
Based on those prior studies I expected that F. tularensis could infect both macrophages 
and lung epithelial cells. While macrophages are typically the focus of tularemia research, lung 
epithelial cells could also be important. There are far more epithelial cells along the surface of 
the lungs for bacteria to interact with than macrophages. Type II epithelial cells exchange gas 
and maintain a fluid balance. Their proximity to endothelial cells could aid in the dissemination 
of bacteria [3]. We found that F. tularensis can replicate at similar rates within A549 and J774 
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cells. Although, we found that the bacteria can infect more J774 cells initially than A549 cells. 
Due to the phagocytic nature of J774 cells this was an expected result. In our study, we found 
that the infection efficiency was lower than one percent. Hall and associates found that 0.2% of 
A549 cells were infected after six hours of infection. In comparison the Tc-1 cell line, a mouse 
lung epithelial cell line, had as high as 17% infected cells. They also found that both the Tc-1 
and A549 cell lines had less infected cells than the J774A.1 cell line [12]. Also, one group found 
that 0.05%-0.1% of the inoculum had successfully infected Hep-2 cells, human bronchial 
epithelial cells and A549 cells after four hours of infection [19]. Even though our infection 
efficiencies were lower than these, our infection time was half or a third of these previous study 
infection times. Ultimately, these data together suggest that F. tularensis can infect both 
macrophages and lung epithelial cells at low rates initially. However, once the F. tularensis 
infected either cell type, it can replicate and infect other cells.  
Hall et al. found that Francisella localizes to the alveolar regions of the lungs of infected 
mice one to seven days post-exposure to LVS. They saw very few bacteria in the apical surfaces 
of the bronchial epithelial cells. They also did not see any replication of bacteria with bronchial 
epithelial cells [12].  However, Lindemann et al. found that LVS was able to infect human 
bronchial epithelial cells. I wanted to infect human primary bronchial epithelial (HBE) cells to 
see if F. tularensis truly can infect human bronchial epithelial cells [19]. Also, the primary HBE 
cells more closely resemble the human lungs. Our preliminary data suggests that F. tularensis 
can infect HBE cells. However, F. tularensis is unable to infect the cells after two hours as seen 
in the A549 experiments. It appears that F. tularensis infects HBE cells at a slower rate than 
A549 cells, since the HBE twenty-four-hour post-infection counts are similar to the two-hour 
post-infection counts of the A549 cells. Future experiments need to be done to confirm these 
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results and to characterize the infection in these cells. Ultimately, this infection assay might be 
useful bridging the gap between the A549 experiment results and the disease in humans.  
Currently, it is unclear which type of cell death is induced by Francisella infection. Lai et 
al. observed pro-caspase 9 and 3 cleavage when they challenged J774 cells with LVS. Also, they 
observed cytochrome c release and degradation of poly-ADP-ribose polymerase and therefore; 
they concluded that Francisella was inducing apoptosis. Other studies found that procaspase-1 
was not necessary to induce cell death. Mice deficient in caspase-1 showed similar pathological 
responses to infection as the wild-type mice. Supporting the idea that the damage caused by cell 
death is not due to caspase-1 induced cell death. Also, the spleens of these mice stained 
positively for fragmented DNA and expressed activated caspase-3 supporting the observation 
that Francisella is causing apoptotic cell death in these animals. However, caspase-3 activation, 
fragmented DNA, necrosis and bacterial dissemination were greater in mice infected with F. 
tularensis isolate KU49 than LVS [25]. Isolate KU49 is more virulent than LVS; therefore, if the 
damage is caused by apoptotic cell death, then the higher levels of caspase-3 activation, 
fragmented DNA, necrosis and bacterial dissemination are expected in mice infected with the 
KU49 isolate. 
In contrast, other studies have shown pro-caspase-1 activation in mouse bone marrow 
derived macrophages after infection with LVS or U112 [25]. Studies with virulent strains of F. 
tularensis have shown low levels of caspase-1 activation [26]. To escape the phagolysosomes, 
the Francisella virulence factor iglC is required. The transcription of virulence factors iglC, 
pdpD and pdpA is regulated by mglA. MglA and pdpA are required to induce macrophage death. 
One group found that macrophages from caspase-1 deficient mice were highly resistant to cell 
death. Also, macrophages from these mice were resistant to F. tularensis-induced death when 
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infected with mglA and pdpA mutants. Therefore, F. tularensis-induced cell death must be 
dependent on bacteria replicating in the cytosol and caspase-1 activation. Similarly, apoptosis-
associated speck-like protein containing CARD (ASC) deficient macrophages were resistant to 
cell death induced by F. tularensis. ASC is an inflammasome adapter protein. Caspase-1 induced 
cell death seems to be a host defense against Francisella infection [27]. I hypothesized that both 
caspase-1 and caspase-3 are induced during Francisella infection. Based on the previous studies, 
it appears that pyroptosis is triggered to remove the bacteria from the cytosol where it replicates; 
however, it does not appear that this is successful in preventing severe disease. Whereas, 
apoptosis may be part of the pathogenesis of Francisella. Tissue damage during infection may be 
due to Francisella inducing apoptosis, since apoptosis is a form of cell death that does not trigger 
an immune response. Therefore, I expected to see positive caspase-1 and caspase-3 results in my 
fluorescent assays. Also, I expected to see positive TUNEL staining and caspase-1 staining in the 
sections from infected rabbit lungs. Unfortunately, I did not see any differences in the fluorescent 
assays. This could have been due to the inability to read at the correct wavelength, errors in the 
performing the assay or many other reasons. Ultimately, this experiment will need to be repeated 
with A549 and HBE cells. My TUNEL stained slides appear to be positive. There is a small 
amount of positive staining in the rabbit sacrificed one day post-exposure. One rabbit that was 
sacrificed two days post-exposure had a high amount of positive staining. The other had a 
medium amount. Both the rabbits sacrificed three days post-exposure had a high amount of 
positive staining. It appears that cell death increases each day post-exposure; therefore, F. 
tularensis infection is inducing cell death. However, these results do not signify the type of cell 
death or the cause of the cell death.  
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Based on previous studies, I expected to see and observed inflammation in the lungs of 
rabbits euthanized two and three-days post-infection. One group studied forty-two hares that 
were found dead due to Francisella. The researchers found that there was mild or no 
inflammation in the liver, spleen and bone marrow of these hares. Necrosis and lesions were 
found on organs throughout many of the hares’ bodies. Francisella was found in the cytoplasm 
of several cells types in the muscle of the hares [28]. However, there is no data on the day-post 
infection that these hares died or how they were infected. Another group infected F344 rats with 
aerosolized SCHU S4. At the time of death, typically four to five days post-infection, the rats 
have high bacterial counts in the lungs, liver and spleen. These rats had developed lung, liver and 
spleen inflammation and severe sepsis. The inflammation was observed in these organs at three 
days post-infection and increased through day seven post-infection [29]. Hares, rabbits and rats 
are not the only animals to develop lung inflammation post-infection with Francisella. Mice 
infected with LVS showed inflammation in the lungs six days post-infection [30]. Also, African 
green monkeys infected with SCHU S4 had hemorrhaging, lesions, edema and congestion in the 
lungs seven to eleven days post-infection [31].  I did see inflammation in the lower left lungs of 
the rabbits sacrificed on days two and three post-infection. Previously the activation of apoptosis 
by F. tularensis was mentioned; however, this seems on the contrary of the inflammation seen in 
the rabbit lungs. The inflammation could be from the immune system triggering pyroptosis to 
prevent F. tularensis from replicating in the cytosol. Cytokines are released during pyroptosis 
that cause inflammation at the site. Only several of the rabbits in our study developed 
inflammation in the lower left lung; however, typically the rabbits develop fevers three to four 
days post-infection. If I looked at tissues from later times points, it is likely that I would see 
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widespread inflammation. Future experiments will focus on different sections of the lung, other 
organs and later timepoints.  
The doses were similar for all our rabbits in this study; however, the rabbits sacrificed on 
day three post-infection had slightly higher doses. The bacteria levels in the BALs were highest 
in the rabbits sacrificed three days post-infection. Since the doses were slightly higher for these 
rabbits and the bacteria has had longer to replicate and spread, this is expected. The lung digest 
CFU and homogenate CFU peak two days post-infection. This is somewhat unexpected since the 
rabbits do not develop fever until three days post-infection. I would expect the CFU to peak on 
day three or four. However, if pyroptosis is occurring between day two and three, it could 
explain the higher BAL and the lower tissue counts. Also, F. tularensis disseminates throughout 
the body, so it may use the epithelial cells proximity to enter the circulatory system by day three.  
Overall, I think that lung epithelial cells do play an important role in F. tularensis 
pathogenesis. I think the proximity to the circulatory system aids in the dissemination of the 
bacteria. If we could prevent F. tularensis from infecting epithelial cells, maybe the infection 
could be prevented. Even though it does infect other cell types, if it cannot infect the epithelium, 
it may not be able to infect enough cells to start a productive infection. Future experimental 
interests include evaluating the caspase levels in A549 and HBE cells, further evaluating caspase 
and TUNEL staining in rabbit tissues, evaluating the metabolic impacts of Francisella infection 
on HBE cells and cytokine analysis.  
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